Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Oxygen is essential to life. The respiratory system works tirelessly to provide fresh oxygen to the body and ensure that all metabolic activities can occur unhindered. The respiratory system is what ...

An inpatient mental health treatment center is one of the best ways to get through an acute (immediate) mental health crisis. Our inpatient mental health center is a safe place where you or a loved ...

Patients with acute COPD exacerbation should be treated with systemic corticosteroids, antibiotics and NPPV. Systemic corticosteroids reduce treatment failures in both in-hospital and outpatient ...

2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al. [30] showed no ...

The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol (hazard ratio, 1.09; 95 percent ...

Background Some patients with COPD ... FE (≥2 exacerbations or 1 hospitalisation due to AECOPD in the previous year) or IE (≤1 exacerbation in the previous year), AECOPD being defined by the ...